| Dr Willard Allen Hauser, MD | |
|
630 W 168th St, New York, NY 10032-3702 | |
| (212) 305-2447 | |
| Not Available |
| Full Name | Dr Willard Allen Hauser |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Clinical Neurophysiology |
| Location | 630 W 168th St, New York, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922003755 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Willard Allen Hauser, MD 265 N Broadway, Nyack, NY 10960-1620 Ph: (212) 305-2447 | Dr Willard Allen Hauser, MD 630 W 168th St, New York, NY 10032-3702 Ph: (212) 305-2447 |
News Archive
An international research collaboration, involving scientists from the UK, US and Spain, has shed new light on the usefulness of digital contact tracing (DCT) to control the spread of Covid-19.
BioMedical Enterprises announced the launch of the Speed Arc Nitinol Fixation System, the world's first superelastic shape memory fixation device that conforms to the sloping surface of the metaphyseal anatomy. This addition to the current patented BME Speed Fixation System is available in three different sizes to ensure a proper fit in varying patient anatomies.
Eidogen-Sertanty, Inc., a San Diego-based computational drug discovery solutions provider, announced today they have licensed their Target Informatics Platform (TIP) to the U.S. Food and Drug Administration's National Center for Toxicological Research (NCTR).
MorphoSys AG's (FSE: MOR; Prime Standard Segment, TecDAX) partner OncoMed Pharmaceuticals today announced that Proceedings of the National Academy of Sciences of the United States of America (PNAS) has published online data demonstrating the potent anti-cancer activity of OMP-18R5, a HuCAL antibody targeting the Wnt pathway, in multiple preclinical human tumor models. OMP-18R5 is currently in Phase 1 clinical testing.
Despite widespread capacity to provide prescription medication labels in languages other than English, few New York City pharmacies do so and as a result, limited-English patients face serious risk of medication error, according to a study by The New York Academy of Medicine presented at the annual meeting of the Society for General Internal Medicine (SGIM) in Toronto, Ontario.
› Verified 6 days ago
Dr. Jahannaz Dastgir, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 710 W 168th St, New York, NY 10032 Phone: 646-426-3876 Fax: 212-342-6865 | |
Dr. Lawrence S, Kegeles, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1051 Riverside Drive, Unit 31, New York, NY 10032 Phone: 212-543-5497 Fax: 212-568-6171 | |
Dr. Risa Ribakove, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 135 E 12th St, Second Floor, New York, NY 10003 Phone: 212-229-1671 | |
Dr. Laura Raquel Sirulnik, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 15 W 63rd St Apt 33a, New York, NY 10023 Phone: 646-258-8535 | |
Dr. Amanda Moberg Wilson, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 21 W 86th St, Suite 209, New York, NY 10024 Phone: 917-715-2886 | |
Dr. Jose Dtm Gutierrez, MD, MPH Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 710 W 168th St, 6th Floor, New York, NY 10032 Phone: 212-305-8389 | |
Nathaniel Mendelsohn, Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 950 Park Ave, New York, NY 10028 Phone: 646-389-1447 |